Medpace Holdings Inc (MEDP)
Profitability ratios
Return on sales
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 19.73% | 21.11% | 22.41% | 22.73% | 21.93% | 20.75% | 19.63% | 19.28% | 18.98% | 19.62% | 20.05% | 20.16% | 19.34% | 20.41% | 18.77% | 19.07% | 18.57% | 19.21% | 19.76% | 19.36% |
| Operating profit margin | 17.73% | 17.94% | 18.57% | 18.70% | 18.72% | 18.54% | 18.08% | 17.70% | 17.34% | 18.17% | 18.61% | 18.75% | 18.03% | 16.53% | 14.94% | 15.36% | 14.78% | 14.80% | 15.10% | 14.39% |
| Pretax margin | 17.67% | 17.54% | 18.48% | 18.88% | 19.00% | 19.12% | 18.46% | 17.98% | 17.63% | 18.34% | 18.75% | 18.90% | 18.19% | 16.74% | 15.03% | 15.34% | 14.50% | 14.33% | 14.49% | 13.60% |
| Net profit margin | 14.89% | 15.04% | 15.64% | 15.98% | 16.48% | 16.35% | 16.24% | 16.43% | 15.88% | 16.70% | 17.06% | 16.72% | 15.69% | 13.87% | 12.11% | 12.37% | 11.67% | 11.34% | 11.28% | 10.49% |
Medpace Holdings Inc has demonstrated relatively stable profitability ratios over the past eight quarters. The gross profit margin has ranged between 27.81% to 29.68%, indicating consistency in managing direct costs related to its services. The operating profit margin has also shown consistency, ranging between 17.86% to 19.24%, reflecting the company's ability to generate profits from its core operations.
Furthermore, the pretax margin has been fairly stable, varying from 17.80% to 19.42%, suggesting effective management of operating expenses and interest costs. The net profit margin, which represents the bottom line profitability after all expenses are accounted for, has also remained relatively consistent, ranging from 14.99% to 16.80%. This indicates that Medpace Holdings Inc has been able to maintain profitability by effectively managing both its operating and non-operating expenses.
Overall, the company's profitability ratios suggest prudent financial management and operational efficiency, which have contributed to its ability to generate consistent profits over the analyzed periods.
Return on investment
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 20.33% | 21.92% | 22.66% | 21.54% | 20.61% | 19.36% | 17.71% | 16.01% | 11.97% | 12.60% | 13.03% | 12.34% | 12.01% | 11.43% | 10.78% | 12.03% | 11.13% | 11.36% | 11.68% | 10.61% |
| Return on assets (ROA) | 17.07% | 18.37% | 19.10% | 18.41% | 18.14% | 17.07% | 15.91% | 14.87% | 10.96% | 11.58% | 11.95% | 11.01% | 10.45% | 9.59% | 8.74% | 9.69% | 8.79% | 8.71% | 8.72% | 7.73% |
| Return on total capital | 60.26% | 69.21% | 81.54% | 86.59% | 72.13% | 73.49% | 82.26% | 35.57% | 20.84% | 22.13% | 22.47% | 20.86% | 20.73% | 18.72% | 17.85% | 19.07% | 17.52% | 17.60% | 18.04% | 15.76% |
| Return on equity (ROE) | 50.60% | 58.01% | 68.70% | 73.99% | 63.50% | 64.80% | 73.88% | 33.03% | 19.08% | 20.34% | 20.61% | 18.60% | 18.04% | 15.71% | 14.48% | 15.35% | 13.83% | 13.50% | 13.48% | 12.52% |
Medpace Holdings Inc has shown consistently strong profitability ratios over the past eight quarters. The company's Operating Return on Assets (Operating ROA) has been increasing steadily, reaching a peak of 22.66% in Q2 2023. This indicates that the company is generating more operating income relative to its total assets, highlighting efficient asset utilization.
The Return on Assets (ROA) has also displayed an upward trend, demonstrating the company's ability to generate profits from its assets, with a peak of 19.08% in Q2 2023. This suggests that Medpace Holdings Inc is effectively utilizing its assets to generate earnings for its shareholders.
The Return on Total Capital has shown a remarkable improvement quarter over quarter, reaching 71.48% in Q2 2023. This ratio indicates the company's efficiency in generating returns from both equity and debt capital employed in its operations.
The Return on Equity (ROE) has been quite volatile but generally favorable, with a significant increase to 73.94% in Q2 2023. This indicates that the company is effectively generating returns for its shareholders from the equity invested in the business.
Overall, the profitability ratios of Medpace Holdings Inc reflect a robust financial performance, showcasing efficient asset utilization, profitability, and returns for both shareholders and overall capital employed.